Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Debt / NOTE 2.875% 1/1
-
Number of holders
-
27
-
Total 13F principal, excl. options
-
229,679,898
-
Principal change
-
-16,879,136
-
Total reported value, excl. options
-
$293,411,749
-
Value change
-
-$23,255,011
-
Number of buys
-
7
-
Number of sells
-
-19
-
Price
-
$1.28
Significant Holders of EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 as of Q4 2016
34 filings reported holding 29089QAB1 - EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 as of Q4 2016.
EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 has 27 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $229,679,898 of principal
.
Largest 10 bondholders include Calamos Advisors LLC ($37,964,000 of principal), Linden Advisors LP ($36,545,000 of principal), CNH PARTNERS LLC ($30,400,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($25,500,000 of principal), UBS ASSET MANAGEMENT AMERICAS INC ($16,500,000 of principal), LAZARD ASSET MANAGEMENT LLC ($15,041,000 of principal), Polar Asset Management Partners Inc. ($10,000,000 of principal), ANGELO GORDON & CO., L.P. ($8,500,000 of principal), CREDIT SUISSE AG/ ($8,200,000 of principal), and Paloma Partners Management Co ($7,330,000 of principal).
This table shows the top 27 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.